Alpha 2.0
Login Register
» Articles » PMID: 4121910

Hyperthyroidism As a Possible Complication of the Treatment of Ischemic Heart Disease with Amiodarone

Overview
Journal Acta Cardiol
Specialty Cardiology & Vascular Diseases
Date 1973 Jan 1
PMID 4121910
Citations 13
Authors
M H JONCKHEER
P Blockx
R KAIVERS
G Wyffels
Affiliations
Soon will be listed here.
Citing Articles

Thyroid Dysfunction under Amiodarone in Patients with and without Congenital Heart Disease: Results of a Nationwide Analysis.

Fischer A, Enders D, Eckardt L, Kobe J, Wasmer K, Breithardt G J Clin Med. 2022; 11(7).

PMID: 35407633 PMC: 8999848. DOI: 10.3390/jcm11072027.

Treatment of amiodarone iodine-induced thyrotoxicosis with plasmapheresis and methimazole.

Aghini-Lombardi F, Mariotti S, FOSELLA P, Grasso L, Pinchera A, Braverman L J Endocrinol Invest. 1993; 16(10):823-6.

PMID: 8144857 DOI: 10.1007/BF03348934.

Amiodarone-induced thyrotoxicosis: four cases and a review of the literature.

Keidar S, Grenadier E, Palant A Postgrad Med J. 1980; 56(655):356-8.

PMID: 7443598 PMC: 2425617. DOI: 10.1136/pgmj.56.655.356.

Electrophysiological assessment of amiodarone in treatment of resistant supraventricular arrhythmias.

Rowland E, Krikler D Br Heart J. 1980; 44(1):82-90.

PMID: 7426165 PMC: 482364. DOI: 10.1136/hrt.44.1.82.

Pharmacokinetics of amiodarone after intravenous and oral administration.

Andreasen F, Agerbaek H, Bjerregaard P, GOTZSCHE H Eur J Clin Pharmacol. 1981; 19(4):293-9.

PMID: 7286032 DOI: 10.1007/BF00562807.